{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T15:27:57Z","timestamp":1758814077412,"version":"3.41.2"},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1111\/igc.0b013e3181a4071d","type":"journal-article","created":{"date-parts":[[2010,12,3]],"date-time":"2010-12-03T13:53:16Z","timestamp":1291384396000},"page":"756-760","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Assessment of Promising Protein Markers for Vulva Cancer"],"prefix":"10.1016","volume":"19","author":[{"given":"Guus","family":"Fons","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthe P.M.","family":"Burger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiebo J.W.","family":"ten Kate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacobus","family":"van der Velden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/IGC.0b013e3181a4071d_bb0005","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/0002-9378(92)91623-I","article-title":"In situ and invasive vulvar cancer incidence trends (1973 to 1987)","volume":"166","author":"Sturgeon","year":"1992","journal-title":"Am J Obstet Gynecol."},{"key":"10.1111\/IGC.0b013e3181a4071d_bb0010","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.ygyno.2006.10.004","article-title":"Margin distance and other clinico-pathologic prognostic factors in vulvar carcinoma: a multivariate analysis","volume":"104","author":"Chan","year":"2007","journal-title":"Gynecol Oncol."},{"key":"10.1111\/IGC.0b013e3181a4071d_bb0015","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/0002-9378(91)90573-A","article-title":"Assessment of current International Federation of Gynecology and Obstetrics staging of vulvar carcinoma relative to prognostic factors for survival (a Gynecologic Oncology Group study)","volume":"164","author":"Homesley","year":"1991","journal-title":"Am J Obstet Gynecol."},{"key":"10.1111\/IGC.0b013e3181a4071d_bb0020","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/1097-0142(20000701)89:1<116::AID-CNCR16>3.0.CO;2-4","article-title":"Patterns of recurrence in patients with squamous cell carcinoma of the vulva. A multicenter CTF Study","volume":"89","author":"Maggino","year":"2000","journal-title":"Cancer."},{"key":"10.1111\/IGC.0b013e3181a4071d_bb0025","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1002\/(SICI)1097-0142(20000415)88:8<1869::AID-CNCR16>3.0.CO;2-U","article-title":"Recurrent squamous cell carcinoma of the vulva: clinicopathologic determinants identifying low risk patients","volume":"88","author":"Preti","year":"2000","journal-title":"Cancer."},{"key":"10.1111\/IGC.0b013e3181a4071d_bb0030","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/nm0798-844","article-title":"Tissue microarrays for high-throughput molecular profiling of tumor specimens","volume":"4","author":"Kononen","year":"1998","journal-title":"Nat Med."},{"key":"10.1111\/IGC.0b013e3181a4071d_bb0035","doi-asserted-by":"crossref","DOI":"10.1097\/01.pgp.0000228140.94339.db","article-title":"Identification of potential prognostic markers for vulvar cancer using immunohistochemical staining of tissue micro arrays","author":"Fons","year":"2007","journal-title":"Int J Gynecol Pathol."},{"key":"10.1111\/IGC.0b013e3181a4071d_bb0040","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ygyno.2006.07.035","article-title":"EGFR expression is associated with groin node metastases in vulvar cancer, but does not improve their prediction","volume":"104","author":"Oonk","year":"2007","journal-title":"Gynecol Oncol."},{"key":"10.1111\/IGC.0b013e3181a4071d_bb0045","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ygyno.2004.07.026","article-title":"p16INK4a and p21Waf1\/Cip1 expression correlates with clinical outcome in vulvar carcinomas","volume":"95","author":"Knopp","year":"2004","journal-title":"Gynecol Oncol."},{"key":"10.1111\/IGC.0b013e3181a4071d_bb0050","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/00004347-199907000-00001","article-title":"Squamous cell carcinoma of the vulva: study of ploidy, HPV, p53, and pRb","volume":"18","author":"Lerma","year":"1999","journal-title":"Int J Gynecol Pathol."},{"key":"10.1111\/IGC.0b013e3181a4071d_bb0055","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1006\/gyno.1999.5655","article-title":"Expression of Ki-67 in vulvar carcinoma and vulvar intraepithelial neoplasia III: correlation with clinical prognostic factors","volume":"76","author":"Modesitt","year":"2000","journal-title":"Gynecol Oncol."},{"year":"2004","series-title":"Basis & Clinical Biostatistics","author":"Dawson","key":"10.1111\/IGC.0b013e3181a4071d_bb0060"},{"key":"10.1111\/IGC.0b013e3181a4071d_bb0065","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/01.pgp.0000177646.38266.6a","article-title":"Vulvar squamous cell carcinoma is a multifactorial disease following two separate and independent pathways","volume":"25","author":"VDI","year":"2006","journal-title":"Int J Gynecol Pathol."},{"key":"10.1111\/IGC.0b013e3181a4071d_bb0070","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1053\/ejso.2002.1338","article-title":"Prognostic significance of caspase-3 expression in primary resected esophageal squamous cell carcinoma","volume":"29","author":"Hsia","year":"2003","journal-title":"Eur J Surg Oncol."},{"key":"10.1111\/IGC.0b013e3181a4071d_bb0075","first-page":"1747","article-title":"Relevance of proliferative and pro-apoptotic factors in non-small-cell lung cancer for patient survival","volume":"82","author":"Volm","year":"2000","journal-title":"Br J Cancer."},{"key":"10.1111\/IGC.0b013e3181a4071d_bb0080","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1158\/1078-0432.CCR-03-0354","article-title":"Prognostic significance of cyclooxygenase-2 in oropharyngeal squamous cell carcinoma","volume":"10","author":"Chang","year":"2004","journal-title":"Clin Cancer Res."},{"key":"10.1111\/IGC.0b013e3181a4071d_bb0085","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S1368-8375(03)00105-2","article-title":"Immunohistochemical study on overexpression of cyclooxygenase-2 in squamous cell carcinoma of the oral cavity: its importance as a prognostic predictor","volume":"39","author":"Itoh","year":"2003","journal-title":"Oral Oncol."},{"key":"10.1111\/IGC.0b013e3181a4071d_bb0090","first-page":"1073","article-title":"Correlation of cyclooxygenase-2 pathway and VEGF expression in head and neck squamous cell carcinoma","volume":"10","author":"Lim","year":"2003","journal-title":"Oncol Rep."},{"key":"10.1111\/IGC.0b013e3181a4071d_bb0095","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.ygyno.2003.10.054","article-title":"Expression of cyclooxygenase-2 (COX-2) in non-neoplastic and neoplastic vulvar epithelial lesions","volume":"92","author":"Ferrandina","year":"2004","journal-title":"Gynecol Oncol."},{"key":"10.1111\/IGC.0b013e3181a4071d_bb0100","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1093\/carcin\/bgi304","article-title":"Significance of COX-2 expression in human esophageal squamous cell carcinoma","volume":"27","author":"Zhi","year":"2006","journal-title":"Carcinogenesis."},{"key":"10.1111\/IGC.0b013e3181a4071d_bb0105","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/sj.neo.7900182","article-title":"The growth of malignant keratinocytes depends on signaling through the PGE(2) receptor EP1","volume":"3","author":"Thompson","year":"2001","journal-title":"Neoplasia."},{"key":"10.1111\/IGC.0b013e3181a4071d_bb0110","first-page":"3","article-title":"Molecular pathology of cyclooxygenase-2 in neoplasia","volume":"30","author":"Fosslien","year":"2000","journal-title":"Ann Clin Lab Sci."},{"key":"10.1111\/IGC.0b013e3181a4071d_bb0115","first-page":"325","article-title":"Review: molecular pathology of cyclooxygenase-2 in cancer-induced angiogenesis","volume":"31","author":"Fosslien","year":"2001","journal-title":"Ann Clin Lab Sci."},{"key":"10.1111\/IGC.0b013e3181a4071d_bb0120","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2174\/187152006776930891","article-title":"Mechanisms leading to COX-2 expression and COX-2 induced tumorigenesis: topical therapeutic strategies targeting COX-2 expression and activity","volume":"6","author":"Telliez","year":"2006","journal-title":"Anticancer Agents Med Chem."},{"key":"10.1111\/IGC.0b013e3181a4071d_bb0125","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1196\/annals.1397.014","article-title":"The cyclooxygenase-2 selective inhibitor celecoxib suppresses proliferation and invasiveness in the human oral squamous carcinoma","volume":"1095","author":"Kwak","year":"2007","journal-title":"Ann N Y Acad Sci."},{"key":"10.1111\/IGC.0b013e3181a4071d_bb0130","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/(SICI)1097-0215(19990827)82:5<648::AID-IJC6>3.0.CO;2-D","article-title":"Prostaglandin-H-synthase isozyme expression in normal and neoplastic human skin","volume":"82","author":"Muller-Decker","year":"1999","journal-title":"Int J Cancer."},{"key":"10.1111\/IGC.0b013e3181a4071d_bb0135","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/j.1365-2133.2004.06214.x","article-title":"Cyclooxygenase-2 expression and angiogenesis in squamous cell carcinoma of the skin and its precursors: a paired immunohistochemical study of 35 cases","volume":"151","author":"Nijsten","year":"2004","journal-title":"Br J Dermatol."},{"key":"10.1111\/IGC.0b013e3181a4071d_bb0140","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.ygyno.2007.05.007","article-title":"The role of angiogenesis and COX-2 expression in the evolution of vulvar lichen sclerosus to squamous cell carcinoma of the vulva","volume":"106","author":"Raspollini","year":"2007","journal-title":"Gynecol Oncol."},{"key":"10.1111\/IGC.0b013e3181a4071d_bb0145","doi-asserted-by":"crossref","first-page":"6261","DOI":"10.1158\/1078-0432.CCR-04-2102","article-title":"Tumor growth inhibition by simultaneously blocking epidermal growth factor receptor and cyclooxygenase-2 in a xenograft model","volume":"11","author":"Zhang","year":"2005","journal-title":"Clin Cancer Res."}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2FIGC.0b013e3181a4071d","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24039872?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24039872?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T01:17:44Z","timestamp":1753233464000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24039872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["S1048891X24039872"],"URL":"https:\/\/doi.org\/10.1111\/igc.0b013e3181a4071d","relation":{},"ISSN":["1048-891X"],"issn-type":[{"type":"print","value":"1048-891X"}],"subject":[],"published":{"date-parts":[[2009,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of Promising Protein Markers for Vulva Cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/IGC.0b013e3181a4071d","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright Copyright \u00a9 2009 by IGCS and ESGO","name":"copyright","label":"Copyright"}]}}